The largest database of trusted experimental protocols

Anti tissue factor antibody

Manufactured by Santa Cruz Biotechnology
Sourced in United States

The Anti-tissue factor (TF) antibody is a laboratory reagent used for the detection and study of tissue factor, a protein involved in the initiation of the blood coagulation cascade. This antibody can be used in various experimental techniques such as immunohistochemistry, Western blotting, and flow cytometry to identify and quantify the presence of tissue factor in biological samples.

Automatically generated - may contain errors

2 protocols using anti tissue factor antibody

1

Anticoagulant and Platelet Aggregation Assays

Check if the same lab product or an alternative is used in the 5 most similar protocols
Heparin was purchased from Sigma (St. Louis, MO, USA) and TNF-α was purchased from Abnova (Taipei, Taiwan). The molecular weight of Heparin used as positive control in our experiments is 3500. Anti-tissue factor (TF) antibody, rivaroxaban, and argatroban were purchased from Santa Cruz Biotechnology, Inc. (Dallas, TX, USA). Thromboxane A2 (TXA2) analog and U46619 were purchased from Calbiochem-Novabiochem Corp. (San Diego, CA, USA). Prothrombin, thrombin, Factor VIIa, X, and Xa were purchased from Haematologic Technologies (Essex Junction, VT, USA) and APTT-XL and thromboplastin-D were purchased from Fisher Diagnostics (Middletown, VA, USA). S-2222 and S-2238 were purchased as substrate of FXa and thrombin from ChromogenixAB (Mölndal, Sweden). Aggregometer (Chronlog, Havertown, PA, USA), thrombotimer (Behnk Elektronik, Norderstedt, Germany), microplate reader (Tecan Austria GmbH, Grödig, Austria), and spectrophotometer (TECAN, Männedorf, Switzerland) were used.
+ Open protocol
+ Expand
2

Anticoagulant Effects of Freeze-dried Oxya

Check if the same lab product or an alternative is used in the 5 most similar protocols
Freeze-dried Oxya chinensis sinuosa (5 kg) were obtained from the National Academy of Agricultural Science, RDA, Korea, and identified by one of the authors (M-A. Kim). A voucher specimen (CNU-INS 201603) was deposited at the Pharmacognosy Laboratory of the College of Pharmacy, Chungnam National University, Daejeon, Korea. TNF-α was purchased from Abnova (Taipei, Taiwan). The anti-tissue factor (TF) antibody was purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA, USA). The thromboxane A2 (TXA2) analog, U46619, was purchased from Calbiochem-Novabiochem Corp. (San Diego, CA, USA). Factors VIIa, X, and Xa, and thrombin were obtained from Haematologic Technologies (Essex Junction, VT, USA). Recombinant tissue factor pathway inhibitor (TFPI) was obtained from Amercian Diagnostica Inc (Stamford, CT, USA). The aPTT assay reagent and PT reagents were purchased from Fisher Diagnostics (Middletown, VA, USA); the chromogenic substrate (S-2222) was purchased from Chromogenix AB (Mölndal, Sweden). Collagen and tirofiban were purchased from Sigma (St. Louis, MO, USA). All other reagents were of the highest commercially available grade.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!